FI950010L - Användning av bradykininantagonister för framställning av läkemedel för behandling av virussjukdomar - Google Patents

Användning av bradykininantagonister för framställning av läkemedel för behandling av virussjukdomar Download PDF

Info

Publication number
FI950010L
FI950010L FI950010A FI950010A FI950010L FI 950010 L FI950010 L FI 950010L FI 950010 A FI950010 A FI 950010A FI 950010 A FI950010 A FI 950010A FI 950010 L FI950010 L FI 950010L
Authority
FI
Finland
Prior art keywords
medicaments
preparation
treatment
viral diseases
bradykinin antagonists
Prior art date
Application number
FI950010A
Other languages
English (en)
Finnish (fi)
Other versions
FI117320B (sv
FI950010A0 (sv
Inventor
Klaus Wirth
Irvin Winkler
Fred Lembeck
Gerhard Breipohl
Stephan Henke
Jochen Knolle
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI950010A0 publication Critical patent/FI950010A0/sv
Publication of FI950010L publication Critical patent/FI950010L/sv
Application granted granted Critical
Publication of FI117320B publication Critical patent/FI117320B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/043—Kallidins; Bradykinins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/18—Kallidins; Bradykinins; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI950010A 1993-12-31 1995-01-02 Användning av bradykininantagonister för framställning av läkemedel för behandling av virussjukdomar FI117320B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4345062A DE4345062A1 (de) 1993-12-31 1993-12-31 Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von Viruserkrankungen

Publications (3)

Publication Number Publication Date
FI950010A0 FI950010A0 (sv) 1995-01-02
FI950010L true FI950010L (sv) 1995-07-01
FI117320B FI117320B (sv) 2006-09-15

Family

ID=6506576

Family Applications (1)

Application Number Title Priority Date Filing Date
FI950010A FI117320B (sv) 1993-12-31 1995-01-02 Användning av bradykininantagonister för framställning av läkemedel för behandling av virussjukdomar

Country Status (21)

Country Link
US (1) US5789383A (sv)
EP (1) EP0661058B1 (sv)
JP (1) JP3828593B2 (sv)
KR (1) KR100358822B1 (sv)
CN (1) CN1119171C (sv)
AT (1) ATE255417T1 (sv)
AU (1) AU696629B2 (sv)
BR (1) BR9405308A (sv)
CA (1) CA2138933C (sv)
DE (2) DE4345062A1 (sv)
DK (1) DK0661058T3 (sv)
ES (1) ES2211874T3 (sv)
FI (1) FI117320B (sv)
HU (1) HU226374B1 (sv)
IL (1) IL112183A (sv)
MY (1) MY112888A (sv)
NO (1) NO317660B1 (sv)
PT (1) PT661058E (sv)
RU (1) RU2228195C2 (sv)
UA (1) UA41326C2 (sv)
ZA (1) ZA9410381B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2737408B1 (fr) * 1995-07-31 1997-09-05 Oreal Utilisation d'un antagoniste de bradykinine dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
DE19612067A1 (de) * 1996-03-27 1997-10-02 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von chronisch fibrogenetischen Lebererkrankungen und akuten Lebererkrankungen
WO2016170382A1 (en) * 2015-04-23 2016-10-27 INSERM (Institut National de la Santé et de la Recherche Médicale) Pharmaceutical compositions comprising a bradykinin 2 receptor antagonist for prevention or treatment of impaired skin wound healing
PL3464336T3 (pl) 2016-06-01 2022-05-16 Athira Pharma, Inc. Związki

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE63490B1 (en) * 1988-11-24 1995-05-03 Hoechst Ag Peptides having bradykinin antagonist action
MX9100717A (es) * 1990-08-24 1992-04-01 Syntex Inc Antagonistas de la bradiquinina
DK31991D0 (da) * 1991-02-25 1991-02-25 Carlbiotech Ltd As Peptid og farmaceutisk praeparat indeholdende et saadant peptid
HUT65328A (en) * 1991-04-01 1994-05-02 Cortech Process for producing bradykinin antagonists
DE69226708T2 (de) * 1991-04-19 1999-04-15 Scios Nova Inc., Mountain View, Calif. Bradykinin typische peptide
DE69231918D1 (de) * 1991-04-19 2001-08-09 Scios Nova Inc Peptidantagonisten des bradykinin
US5240694A (en) * 1991-09-23 1993-08-31 University Of Virginia Combined antiviral and antimediator treatment of common colds
RU2043115C1 (ru) * 1992-06-11 1995-09-10 Товарищество с ограниченной ответственностью "Резонанс-фарма" Средство, повышающее выживаемость и облегчающее течение вирусной инфекции - экстромелии в эксперименте
AU680870B2 (en) * 1993-04-28 1997-08-14 Astellas Pharma Inc. New heterocyclic compounds
WO1996006083A1 (en) * 1994-08-24 1996-02-29 Pfizer Pharmaceuticals Inc. 2-(piperazinyl-1-carbonylmethyl)-1,4-dihydropyridines as bradykinin antagonists

Also Published As

Publication number Publication date
JP3828593B2 (ja) 2006-10-04
KR100358822B1 (ko) 2003-01-24
FI117320B (sv) 2006-09-15
ZA9410381B (en) 1995-08-29
BR9405308A (pt) 1995-09-19
KR950016779A (ko) 1995-07-20
DK0661058T3 (da) 2004-04-05
AU8179194A (en) 1995-07-13
JPH07206703A (ja) 1995-08-08
AU696629B2 (en) 1998-09-17
IL112183A0 (en) 1995-03-15
CN1108138A (zh) 1995-09-13
CN1119171C (zh) 2003-08-27
CA2138933A1 (en) 1995-07-01
RU94045140A (ru) 1996-10-20
DE4345062A1 (de) 1995-07-13
NO317660B1 (no) 2004-11-29
NO945094L (no) 1995-07-03
MY112888A (en) 2001-10-31
ES2211874T3 (es) 2004-07-16
UA41326C2 (uk) 2001-09-17
HU9403783D0 (en) 1995-02-28
ATE255417T1 (de) 2003-12-15
RU2228195C2 (ru) 2004-05-10
CA2138933C (en) 2010-02-23
FI950010A0 (sv) 1995-01-02
NO945094D0 (no) 1994-12-30
DE59410340D1 (de) 2004-01-15
EP0661058A1 (de) 1995-07-05
HUT71422A (en) 1995-11-28
PT661058E (pt) 2004-04-30
EP0661058B1 (de) 2003-12-03
US5789383A (en) 1998-08-04
HU226374B1 (en) 2008-10-28
IL112183A (en) 2001-01-11

Similar Documents

Publication Publication Date Title
NO904694L (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater.
NO901684L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater.
FI990268A0 (sv) Användning av en icke-peptid-NK-antagonist för framställning av läkemedel avsedda för behandling av hudsjukdomar och klåda
NO914036L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater
AU4048295A (en) Peptide medicaments for the treatment of disease
NO903088L (no) Fremgangsmaate for fremstilling av terapeutisk aktive diazepin-derivater.
NO904986L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive diazepin-derivater.
FI910413A7 (sv) Topiska preparat för behandling av människonaglar
NO902411D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-hydroksy-n-propylaminer.
DK19893A (da) Praeparat til nasal behandling
ZA983602B (en) Use of tetrahydropyridine derivatives for the preparation of drugs for the treatment of diseases which cause demyelination
DE69420229D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
AU9173191A (en) Medicaments for the treatment of papillomavirus diseases
AU3684395A (en) Use of camptothecin or derivatives thereof for the manufacture of a medicament for the treatment of viral diseases
NO914071D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser
NO991164D0 (no) Farmas°ytisk preparat for behandling av virussykdommer
FI950010L (sv) Användning av bradykininantagonister för framställning av läkemedel för behandling av virussjukdomar
NO168477C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kondenserte diazepinoner.
NO900972D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater.
FI961494L (sv) Farmaceutiska kompositioner och användning av dem, särskilt för behandling av neurodegenerativa sjukdomar
NO903939L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kondenserte diazepinoner.
NO892871D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO900942D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive azacyklooktadien-derivater.
ZA944671B (en) Medicaments for the treatment of inflammatory diseases
NO904470D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzodiazepinderivater.

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 117320

Country of ref document: FI

MA Patent expired